您要查找的是不是：
- Neoadjuant chemoradiotherapy 新辅助化放疗
- The patient underwent a full course of concurrent chemoradiotherapy. 患者接受了一完整的合并化学放射治疗。
- In this article, we reiew our long-term experience of neoadjuant chemotherapy of adanced stage (III-IA) thymomas. 在本文中，我们回顾了晚期(III-IA)胸腺瘤进行新辅助化疗这个长期的过程。
- INTRODUCTION: A main drawback of neoadjuant chemotherapy is that it may increase operatie morbidity and mortality. 引言：新辅助化疗主要的一个缺点是增加术后并发症的发病率和死亡率。
- After chemoradiotherapy, 14 subjects exhibited PR, while 13 showed SD.None of the subjects showed PD. 在化疗后，14名患者显示为PR，13名患者显示为SD，没有一名患者出现PD。
- Combined chemoradiotherapy is increasingly becoming a standard of care for the nonoperative management of a variety of solid malignancies. 联合化放疗已日益成为许多实体恶性肿瘤非手术治疗中的治疗标准。
- CONCLUSION:: The multimodality treatment of stage III and IA thymomas by means of neoadjuant chemotherapy proides good long-term outcomes in both stages of the disease. ：用新辅助化疗的方法治疗III期和IA期胸腺瘤，为这两期患者的治疗提供了良好的长期的预后。
- "Further inestigation is needed to clarify whether serum leels of SLAK in operable lung adenocarcinoma patients influence the necessity of neoadjuant or adjuant chemotherapy," Dr. “要确定肺腺癌病人血清SLAK水平是否会影响新辅助化疗或辅助化疗的使用，尚需要作进一步的研究。”
- The purpose of the chemoradiotherapy is to treat the cancer and, to impair the patient’s immune system to prevent rejection of the donor cells. 化疗目的是治疗癌症，和削弱患者的免疫系统以阻止其对供体细胞的排斥。
- So the higher DWI volumetric tumor reduction rate is more inclined to have negative nodes in rectal cancer with preoperative chemoradiotherapy. 直肠癌术前放化疗过程的不同时间点体积变化无法准确提示肿瘤是否降期。
- A 59-year-old male patient was diagnosed with advanced esophageal cancer in September, 2002.He received 1 course of chemoradiotherapy. 摘要一位五十九岁男性病患于2002年9月诊断晚期食道癌并已接受一个疗程的放射合并化学治疗。
- We administered intraarterial chemoradiotherapy by continuous infusion of carboplatin in 65 cases from January 1993 to July 2002. 我们对从1993年1月到2002年7月的65例患者进行卡铂持续动脉内灌注化疗。
- This article discussed the establishment of concurrent chemoradiotherapy,the possible biological interaction mechanisms and clinical practice. 综合治疗是治疗肿瘤的基本原则,同时放化疗已成为肿瘤临床治疗中最常见的综合治疗形式。
- Nomograms based on long follow-up data from chemoradiotherapy in glioblastoma multiforme can now help to predict the prognosis of the individual patient. 基于多形性胶质母细胞瘤化放疗后的长期随访资料的数据图，现在可以用于预测不同患者的预后。
- Notable malignant myoepithelioma is very rare.The main treatment for malignant myoepithelioma is surgical removal and the effect of chemoradiotherapy is uncertain. 目前治疗方式以外科手术切除为主，而放射线治疗及化学治疗目前还没有确定的模式。
- Neoadjuvant chemoradiotherapy played an important role in the treatment of rectal cancer in order to improve sphincter preservation,decrease relapse and prolong survival. 为了保留肛门、减少复发、延长生存,新辅助化放疗已成为直肠癌治疗的重要组成部分。
- Objective To explore the protective effect of L-Ornithine-L-Aspartate(LOLA) assisted with chemoradiotherapy in patient of lymphoma with hepatitis B virus(HBV). 目的探讨门冬氨酸鸟氨酸在乙肝病毒感染的恶性淋巴瘤放化疗中的保护作用。
- In the treatment of patients with rectal cancer, improed outcomes hae been noted with the use of total mesorectal excision and preoperatie concurrent chemoradiotherapy. 而在直肠癌患者的治疗中，人们已注意到全肠系膜切除和术前联合化疗的使用改善了预后。
- The metastatic tumor on the forearm continued to progress and the patient eventually died of the disease 32 days after diagnosis even after immediate concurrent chemoradiotherapy. 喉镜检查发现下咽部肿瘤，病理切片检查证实为右侧状窝分化不良的鳞状细胞癌，同时前臂病灶切片检查也是与梨状窝切片细胞型态特徵相似的分化不良的鳞状细胞癌。
- The benefit of allogeneic stem cell transplantation for treating blood cancers partly depends on the intensive chemoradiotherapy that is given before stem cell infusion. 异基因造血干细胞移植治疗恶性血液疾病的好处，部分依赖于干细胞输注前的高强度化疗。
